J Veselỳ, A Cihák. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » AnimalsAntimetabolites/therapeutic useAzacitidine/therapeutic useAzauridine/therapeutic useBromouracil/therapeutic useCarcinoma, Ehrlich Tumor/drug therapyCell LineCricetinaeCytarabine/therapeutic useDeoxycytidineDrug ResistanceFluorouracil/therapeutic useGenetic CodeLeukemia, Experimental/drug therapyLeukemia, Lymphoid/drug therapyMast-Cell Sarcoma/drug therapyMiceMutationNeoplasms, Experimental/drug therapyNeoplasms, Experimental/enzymologyOncogenic Viruses/cytologyPhosphotransferases/metabolismPyrimidines/therapeutic useSarcoma, Experimental/drug therapySelection, GeneticThymidine Kinase/metabolismUracil/analogs & derivativesUracil/therapeutic useVirus Replication
Substances: See more » AntimetabolitesPyrimidinesCytarabineDeoxycytidineBromouracilUracilAzauridinePhosphotransferasesThymidine KinaseAzacitidineFluorouracil
Year: 1973 PMID: 4129030 DOI: 10.1159/000224817
Source DB: PubMed Journal: Oncology ISSN: 0030-2414 Impact factor: 2.935